173 related articles for article (PubMed ID: 18450739)
1. Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia.
Itzykson R; Le Garff-Tavernier M; Katsahian S; Diemert MC; Musset L; Leblond V
Haematologica; 2008 May; 93(5):793-4. PubMed ID: 18450739
[No Abstract] [Full Text] [Related]
2. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
3. The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
Leleu X; Xie W; Bagshaw M; Banwait R; Leduc R; Roper N; Weller E; Ghobrial IM
Clin Cancer Res; 2011 May; 17(9):3013-8. PubMed ID: 21415221
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
5. The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia.
Pattenden RJ; Davidson KL; Wenham PR
Ann Clin Biochem; 2009 Nov; 46(Pt 6):531-2. PubMed ID: 19822697
[TBL] [Abstract][Full Text] [Related]
6. Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplant.
Muzaffar J; Katragadda L; Haider S; Abdallah AO; Anaissie E; Usmani SZ
Acta Haematol; 2013; 130(3):146-9. PubMed ID: 23689541
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in Waldenström's macroglobulinemia.
Frase LL; Stone MJ; Sammons CA
Am J Med; 1998 May; 104(5):507-8. PubMed ID: 9626040
[No Abstract] [Full Text] [Related]
8. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
[TBL] [Abstract][Full Text] [Related]
9. Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
Lévy V; Morel P; Porcher R; Chevret S; Wattel E; Leblond V
Haematologica; 2005 Feb; 90(2):279-81. PubMed ID: 15710594
[TBL] [Abstract][Full Text] [Related]
10. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
Krol TC; Wood WS
Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
[No Abstract] [Full Text] [Related]
11. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
Riddell S; Johnston JB; Rayner HL; Israels LG
Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084
[No Abstract] [Full Text] [Related]
12. Waldenström's macroglobulinaemia: a report of five cases.
Rosenberg JN
Guys Hosp Rep; 1971; 120(3):185-96. PubMed ID: 5006264
[No Abstract] [Full Text] [Related]
13. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis.
Merlini G; Sarosiek S; Benevolo G; Cao X; Dimopoulos M; Garcia-Sanz R; Gatt ME; Fernandez de Larrea C; San-Miguel J; Treon SP; Minnema MC
Semin Hematol; 2023 Mar; 60(2):113-117. PubMed ID: 37099030
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation in Waldenström's macroglobulinaemia.
Rozenberg MC; Dintenfass L
Thromb Diath Haemorrh; 1965 Sep; 14(1-2):202-8. PubMed ID: 16955976
[TBL] [Abstract][Full Text] [Related]
15. [Hyperviscosity syndrome and Waldenström's macroglobulinemia].
Shida M; Baba M; Sawada S
Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695
[No Abstract] [Full Text] [Related]
16. [Check-valve-mechanism in Waldenstrom's macroglobulinemia with pericollagen amyloidosis].
Missmahl HP; Gelinsky P; Braun HJ; Dold U
Med Welt; 1969 Jan; 1():39-41. PubMed ID: 4975603
[No Abstract] [Full Text] [Related]
17. [Immunoglobulin amyloidosis].
Hermine O; Bourquelot P; Buzyn A; Aucouturier P
Rev Prat; 1997 Oct; 47(16):1787-91. PubMed ID: 9453204
[TBL] [Abstract][Full Text] [Related]
18. [Waldenstrom's macroglobulinemia, its clinical aspects. Observations on 4 confirmed cases].
Freigang K
Med Welt; 1966 Sep; 39():2053-9. PubMed ID: 4958554
[No Abstract] [Full Text] [Related]
19. [Waldenström's macroglobulinemia with an uncommon presentation].
Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
[TBL] [Abstract][Full Text] [Related]
20. Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Kastritis E; Zervas K; Repoussis P; Michali E; Katodrytou E; Zomas A; Simeonidis A; Terpos E; Delimbassi S; Vassou A; Gika D; Dimopoulos MA;
Clin Lymphoma Myeloma; 2009 Mar; 9(1):50-2. PubMed ID: 19362972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
